Back

Prognostic evaluation of elevation of cardiac biomarkers after myocardial revascularization. Long-term follow-up of MASS-V trial.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Risk management in cardiac surgery Coronary Arteries ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Eduardo Martins

University of Sao Paulo, Sao Paulo (Brazil)

9 More presentations in this session

Presentation thumbnail
Implementation of a specific safety checklist in cardiac surgery is followed by lower postoperative mortality.
Mr A. Spanjersberg (Zwolle, NL)
Abstract Slides Video
Presentation thumbnail
Effect of nutritional status on mortality in patients undergoing coronary artery bypass grafting
Doctor M. Keskin (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Role of a rapid point-of-care platelet function test on bleeding risk prediction in patients undergoing coronary artery bypass grafting surgery
Doctor A. Tello Montoliu (El Palmar, ES)
Abstract
Presentation thumbnail
Preoperatively continued aspirin in elective isolated coronary-artery bypass grafting: a single institutional propensity score matched study
Mr J. Qu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human epicardial and intramyocardial coronary arteries of male patients undergoing coronary artery bypass grafting
Doctor A. Karanasos (Patras, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk management in cardiac surgery

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Anomalous left main coronary artery arising from the right coronary sinus presenting with ST elevation and non ST elevation myocardial infarction
thumbnail
Congress Presentation
Surgical correction of anomalous origin of the coronary artery: a scoping review on clinical outcomes, techniques, and knowledge gaps
thumbnail
Webinar
Chronic coronary syndrome post-myocardial infarction: disease progression and comorbidities

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources